Could lavender oil ease PTSD? new trial aims to find out

NCT ID NCT06412757

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 3 trial tests whether Silexan, a lavender oil extract available over-the-counter, can reduce PTSD symptoms in adults. 278 participants will take Silexan or a placebo daily for 12 weeks alongside their usual treatments. The goal is to see if this well-tolerated supplement offers a new option for those who struggle with current therapies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Silexan (lavender oil extract)
What this could lead to
If it works, this could provide a well-tolerated, over-the-counter option to ease PTSD symptoms for adults.
What could go wrong
This is a Phase 3 trial, but previous evidence is limited to a small pilot study. The effect may be small or no better than placebo. Mild side effects like burping or breath odour are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Austin Health

    RECRUITING

    Heidelberg, Victoria, 3084, Australia

  • Deakin University

    RECRUITING

    Geelong, Victoria, 3220, Australia

  • Ramsay Clinic Albert Road

    RECRUITING

    Melbourne, Victoria, 3004, Australia

  • University of Melbourne

    RECRUITING

    Carlton, Victoria, 5053, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.